Overview
Profile summary
Dr Sheridan is Associate Professor in Hepatology at Peninsula Medical School and Honorary Consultant Hepatologist at the South West Liver Unit, Derriford Hospital. He was Clinical Service Line Director for the South West Liver Unit (2019-2023), until taking up current tenure as Clinical Director of the Medicine Care Group at University Hospitals Plymouth NHS Trust. Research interests are in chronic hepatitis C virus and metabolic-dysfunction associated steatotic liver disease (MASLD).
Professional memberships
GMC 4718282
Royal College of Physicians of London
British Society for the Study of the Liver (BASL)
European Society for the study of the Liver (EASL)
Royal College of Physicians of London
British Society for the Study of the Liver (BASL)
European Society for the study of the Liver (EASL)
Teaching interests
Post Graduate Certificate in Clinical Education, 2015. University of PlymouthAcademic Tutor BMBS years 3 and 4
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where David Sheridan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Autoantibodies to apolipoprotein A-I in hepatitis C virus infection: a role in disease progression?
Bridge, S. H., Pagano, S., Lodge, J. K., Shawa, I. T., Marin-Crespo, P., Cramp, M. E., Sheridan, D. A., Taylor-Robinson, S. D., Vuilleumier, N., Neely, R. D. G. & Bassendine, M. F., 20 Mar 2025, In: Frontiers in Immunology. 16, 1461041.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Downloads (Pure) -
Featured Cover
Mayo, M. J., Vierling, J. M., Bowlus, C. L., Levy, C., Hirschfield, G. M., Neff, G. W., Galambos, M. R., Gordon, S. C., Borg, B. B., Harrison, S. A., Thuluvath, P. J., Goel, A., Shiffman, M. L., Swain, M. G., Jones, D. E. J., Trivedi, P., Kremer, A. E., Aspinall, R. J., Sheridan, D. A. & Dörffel, Y. & 3 others, , 1 Jan 2024, In: Alimentary Pharmacology & Therapeutics. 59, 2Research output: Contribution to journal › Article › peer-review
-
Translating the potential of the urine steroid metabolome to stage NAFLD (TrUSt-NAFLD): Study protocol for a multicentre, prospective validation study
Miller, H., Harman, D., Aithal, G. P., Manousou, P., Cobbold, J. F., Parker, R., Sheridan, D., Newsome, P. N., Karpe, F., Neville, M., Arlt, W., Sitch, A. J., Korbonits, M., Biehl, M., Alazawi, W. & Tomlinson, J. W., 18 Jan 2024, In: BMJ Open. 14, 1, e074918.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Downloads (Pure) -
Developing a risk stratification tool for advanced NAFLD fibrosis using routinely measured clinical variables in a diabetes clinic annual review
Miller, H., Colosimo, S., Li, W., Cobbold, J., Alazawi, W., Harman, D., Aithal, G., Manousou, P., Parker, R., Newsome, P. N., Sheridan, D., Devalia, K., Loy, J. & Tomlinson, J., 1 Jun 2023, In: J Hepatol. 78, p. S708Research output: Contribution to journal › Article › peer-review
-
National study of NAFLD management identifies variation in delivery of care in the UK between 2019 to 2022
Li, W., Sheridan, D., McPherson, S., Alazawi, W., Abeysekera, K., Marjot, T., Brennan, P., Mahgoub, S., Cacciottolo, T., Hydes, T., Hardy, T., McGinty, G., Tavabie, O., Cathcart, J., Premathilaka, C., Mukhopadhya, A., Bhat, A., Begum, S., Abushaban, B. & Bhuva, M. & 66 others, , Dec 2023, In: JHEP Reports. 5, 12Research output: Contribution to journal › Article › peer-review
Open AccessFile66 Downloads (Pure)